Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | 6.20 | 7.64 | 23.07 | 31.82 |
| Cost Of Revenue | 23.24 | 63.06 | 25.12 | 25.72 |
| Gross Profit | -17.04 | -55.42 | -2.04 | 6.11 |
| Operating Expense | 110.02 | 167.41 | 198.82 | 183.36 |
| Operating Income | -127.06 | -222.82 | -200.86 | -177.25 |
| EBITDA | -43.65 | -176.30 | -172.18 | -101.21 |
| EBIT | -51.62 | -210.31 | -217.14 | -136.32 |
| Pretax Income | -51.62 | -214.76 | -223.93 | -157.92 |
| Tax Provision | 0 | -0.63 | -1.39 | -1.31 |
| Net Income | -51.62 | -214.07 | -222.24 | -156.74 |
| Net Income Common Stockholders | -51.62 | -214.07 | -222.24 | -156.74 |
| Total Expenses | 133.26 | 230.47 | 223.94 | 209.07 |
| Interest Expense | 0 | 4.46 | 6.79 | 21.60 |
| Interest Income | 5.23 | 14.07 | 12.33 | 13 |
| Research And Development | 58.05 | 88.39 | 124.51 | 110.33 |
| Selling General And Administration | 51.97 | 79.01 | 74.31 | 73.03 |
| Normalized EBITDA | -113.91 | -175.05 | -142.62 | -127.80 |
| Normalized Income | -121.88 | -212.82 | -192.86 | -183.12 |
| Basic EPS | -0.34 | -1.35 | -1.27 | -0.75 |
| Diluted EPS | -0.82 | -1.38 | -1.27 | -0.75 |
| Tax Effect Of Unusual Items | 0 | 0 | -0.18 | 0.21 |
| Tax Rate For Calcs | 0 | 0 | 0.01 | 0.01 |
| Total Unusual Items | 70.26 | -1.25 | -29.56 | 26.59 |
| Total Unusual Items Excluding Goodwill | 70.26 | -1.25 | -29.56 | 26.59 |
| Net Income From Continuing Operation Net Minority Interest | -51.62 | -214.07 | -222.24 | -156.74 |
| Reconciled Depreciation | 7.97 | 34.01 | 44.96 | 35.11 |
| Reconciled Cost Of Revenue | 23.24 | 63.06 | 25.12 | 25.72 |
| Net Interest Income | 5.23 | 9.61 | 5.54 | -8.60 |
| Net Income From Continuing And Discontinued Operation | -51.62 | -214.07 | -222.24 | -156.74 |
| Total Operating Income As Reported | -131.98 | -230.25 | -242.67 | -177.25 |
| Diluted Average Shares | 154.15 | 159.58 | 175.04 | 207.64 |
| Basic Average Shares | 152.92 | 159.07 | 175.04 | 207.64 |
| Diluted NI Availto Com Stockholders | -126.80 | -220.25 | -222.24 | -156.74 |
| Average Dilution Earnings | -75.18 | -6.18 | 0 | 0 |
| Minority Interests | 0 | 0.06 | 0.29 | -0.13 |
| Net Income Including Noncontrolling Interests | -51.62 | -214.13 | -222.53 | -156.61 |
| Net Income Continuous Operations | -51.62 | -214.13 | -222.53 | -156.61 |
| Other Income Expense | 70.20 | -1.56 | -28.61 | 27.93 |
| Other Non Operating Income Expenses | -0.05 | -0.30 | 0.95 | 1.34 |
| Special Income Charges | -4.92 | -7.43 | -41.81 | 4.76 |
| Impairment Of Capital Assets | 4.92 | 4.41 | 0 | 0 |
| Restructuring And Mergern Acquisition | 0 | 3.02 | 41.81 | -4.76 |
| Gain On Sale Of Security | 75.18 | 6.18 | 12.24 | 21.83 |
| Net Non Operating Interest Income Expense | 5.23 | 9.61 | 5.54 | -8.60 |
| Interest Expense Non Operating | 0 | 4.46 | 6.79 | 21.60 |
| Interest Income Non Operating | 5.23 | 14.07 | 12.33 | 13 |
| Operating Revenue | 6.20 | 7.64 | 23.07 | 31.82 |
